Inpharma Weekly

, Volume 1432, Issue 1, pp 14–14 | Cite as

Temozolomide + irinotecan active in recurrent malignant glioma

Clinical study


Thrombocytopenia Partial Response Recurrent Tumour Disease Stabilisation Irinotecan 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2004

Personalised recommendations